carbogen has been researched along with pentoxifylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dezube, B; Frei, E; Herman, TS; Pardee, A; Tanaka, J; Teicher, BA | 1 |
| Goodchild, K; Hill, S; Hoskin, PJ; Saunders, M; Shah, N; Sibtain, A | 1 |
2 other study(ies) available for carbogen and pentoxifylline
| Article | Year |
|---|---|
Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bone Marrow; Carbon Dioxide; Cell Survival; Colony-Forming Units Assay; Drug Combinations; Drug Interactions; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Indazoles; Male; Mice; Oxygen; Pentoxifylline | 1991 |
The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Carbon Dioxide; Female; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Neoplasms; Niacinamide; Oxygen; Pentoxifylline; Radiation-Sensitizing Agents; Regional Blood Flow; Time Factors; Up-Regulation | 2002 |